140 related articles for article (PubMed ID: 16335687)
1. [Osteoporosis in thyroid diseases].
Kosińska A; Syrenicz A; Kosiński B; Garanty-Bogacka B; Syrenicz M; Gromniak E
Endokrynol Pol; 2005; 56(2):185-93. PubMed ID: 16335687
[TBL] [Abstract][Full Text] [Related]
2. [Bone metabolism and thyroid disease. Normalized bone metabolism prevents osteoporosis].
Tørring O
Lakartidningen; 1993 Jul; 90(28-29):2517-21. PubMed ID: 8326793
[No Abstract] [Full Text] [Related]
3. [The influence of thyroid diseases and their treatment on the development of osteoporosis].
Ciesielska-Kopacz N; Kos-Kudła B; Pluskiewicz W
Przegl Lek; 1998; 55(5):271-3. PubMed ID: 9741195
[TBL] [Abstract][Full Text] [Related]
4. Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.
Reverter JL; Holgado S; Alonso N; Salinas I; Granada ML; Sanmartí A
Endocr Relat Cancer; 2005 Dec; 12(4):973-81. PubMed ID: 16322336
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism.
Affinito P; Sorrentino C; Farace MJ; di Carlo C; Moccia G; Canciello P; Palomba S; Nappi C
Acta Obstet Gynecol Scand; 1996 Oct; 75(9):843-8. PubMed ID: 8931510
[TBL] [Abstract][Full Text] [Related]
6. Thyroid function and postmenopause.
Schindler AE
Gynecol Endocrinol; 2003 Feb; 17(1):79-85. PubMed ID: 12724022
[TBL] [Abstract][Full Text] [Related]
7. [The risk factors and bone mineral density in women on long-term levothyroxine treatment].
López Alvarez MB; Hawkins F; Rigopoulou D; Martínez G; Jodar E; Estenoz J; Ortuño B; Arnaiz F
Med Clin (Barc); 1999 Jan; 112(3):85-9. PubMed ID: 10074614
[TBL] [Abstract][Full Text] [Related]
8. Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.
Sijanovic S; Karner I
Medscape Womens Health; 2001 Oct; 6(5):3. PubMed ID: 11698925
[TBL] [Abstract][Full Text] [Related]
9. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromsø study.
Grimnes G; Emaus N; Joakimsen RM; Figenschau Y; Jorde R
Thyroid; 2008 Nov; 18(11):1147-55. PubMed ID: 18925834
[TBL] [Abstract][Full Text] [Related]
11. Beyond bone mineral density: several factors define bone health.
Ruhl C
Nurs Womens Health; 2008 Jun; 12(3):249-51. PubMed ID: 18557856
[No Abstract] [Full Text] [Related]
12. Overview of bone mineral density in postmenopausal women.
Notelovitz M
J Reprod Med; 2002 Jan; 47(1 Suppl):71-81. PubMed ID: 11829080
[TBL] [Abstract][Full Text] [Related]
13. The impact of thyroid diseases on bone metabolism and fracture risk.
Amashukeli M; Giorgadze E; Tsagareli M; Nozadze N; Jeiranashvili N
Georgian Med News; 2010; (184-185):34-9. PubMed ID: 20834073
[TBL] [Abstract][Full Text] [Related]
14. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
[TBL] [Abstract][Full Text] [Related]
15. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
16. [Impact of thyroid diseases on bone].
Tsourdi E; Lademann F; Siggelkow H
Internist (Berl); 2018 Jul; 59(7):661-667. PubMed ID: 29744522
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of bone density in women after thyroid cancer surgery and treatment with suppressive doses of L-thyroxine].
Jurecka-Tuleja B; August R; Kukulska A; Bartnikowa W; Deja R; Czernik E; Handkiewicz-Junak D
Wiad Lek; 2001; 54 Suppl 1():378-82. PubMed ID: 12182053
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
19. [Bone mineral density in patients on long-term therapy with levothyroxine].
Korsić M; Cvijetić S; Dekanić-Ozegović D; Bolanća S; Kozić B
Lijec Vjesn; 1998 May; 120(5):103-5. PubMed ID: 9748785
[TBL] [Abstract][Full Text] [Related]
20. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma.
Diamond T; Nery L; Hales I
J Clin Endocrinol Metab; 1991 Jun; 72(6):1184-8. PubMed ID: 2026740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
